53 Stock and 47 ETF Atrium Therapeutics (RNA) alternatives
The most close Atrium Therapeutics (RNA) alternative is company Lazydays (GORV). The correlation is 1.
Stocks that highly correlated with RNA
| Symbol | Name | Market cap | Sector | Industry | Correlation |
|---|---|---|---|---|---|
| GORV | Lazydays Holdings Inc | $1.58M | Consumer Cyclical | Auto & Truck Dealerships | 1.00 |
| RHLD | Resolute Holdings Management Inc | $1.12B | Industrials | Specialty Business Services | 0.78 |
| GSRTU | GSR III Acquisition Corp - Units (1 Ord Class A & 1/7 Rts) | $467M | N/A | N/A | 0.67 |
| AGH | Aureus Greenway Holdings Inc | $87M | Consumer Cyclical | Leisure | 0.65 |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | Healthcare | Biotechnology | 0.65 |
| KSPI | Kaspi.kz JSC | $17B | Technology | Software - Infrastructure | 0.64 |
| APGE | Apogee Therapeutics Inc | $10B | Healthcare | Biotechnology | 0.64 |
| UPB | Upstream Bio Inc | $396M | Healthcare | Biotechnology | 0.63 |
| DYN | Dyne Therapeutics Inc | $3.96B | Healthcare | Biotechnology | 0.63 |
| ZBIO | Zenas Biopharma Inc | $1.83B | Healthcare | Biotechnology | 0.61 |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59M | Healthcare | Biotechnology | 0.60 |
| ENTA | Enanta Pharmaceuticals Inc | $384M | Healthcare | Biotechnology | 0.59 |
| VCICU | Vine Hill Capital Investment Corp - Units (1 Ord Class A & 1/2 War) | $75M | Financial Services | Shell Companies | 0.59 |
| ZBAO | Zhibao Technology Inc | $9.18M | Financial Services | Insurance Brokers | 0.58 |
| NRIX | Nurix Therapeutics Inc | $2.47B | Healthcare | Biotechnology | 0.57 |
| PLMKU | Plum Acquisition Corp IV - Units (1 Ord cls A & 1/2 Warr) | $213M | Financial Services | Shell Companies | 0.57 |
| SNDX | Syndax Pharmaceuticals Inc | $2.08B | Healthcare | Biotechnology | 0.57 |
| BIPH | Brookfield Infrastructure Finance ULC | $351K | Healthcare | Medical Instruments & Supplies | 0.55 |
| GAINI | Gladstone Investment Corporation | $1.02B | N/A | N/A | 0.54 |
| PACX | Pioneer Merger Corp - Class A | $513M | N/A | N/A | 0.54 |
| XPDB | Power & Digital Infrastructure Acquisition II Corp - Class A | $634M | N/A | N/A | 0.54 |
| MBX | MBX Biosciences Inc | $2.89B | Healthcare | Biotechnology | 0.53 |
| EFSCP | Enterprise Financial Services Corp | $748M | Financial Services | Banks - Regional | 0.53 |
| CCCC | C4 Therapeutics Inc | $395M | Healthcare | Biotechnology | 0.53 |
| AGNCL | AGNC Investment Corp | $29B | Real Estate | Reit - Mortgage | 0.53 |
| BIOA | BioAge Labs Inc | $1.01B | Healthcare | Drug Manufacturers - Specialty & Generic | 0.51 |
| TY-P | Tri-Continental Corp | $2.48B | N/A | Other | 0.51 |
| JANX | Janux Therapeutics Inc | $976M | Healthcare | Biotechnology | 0.51 |
| NUVB | Nuvation Bio Inc - Class A | $2.04B | Healthcare | Biotechnology | 0.51 |
| BACQU | Bleichroeder Acquisition Corp I - Units (1 Ord Class A & 1/3 War) | $781M | Financial Services | Shell Companies | 0.51 |
| SCCE | Sachem Capital Corp | $1.18B | N/A | N/A | 0.51 |
| SION | Sionna Therapeutics Inc | $2B | Healthcare | Biotechnology | 0.50 |
| VKTX | Viking Therapeutics Inc | $4.38B | Healthcare | Biotechnology | 0.50 |
| OCUL | Ocular Therapeutix Inc | $2.18B | Healthcare | Biotechnology | 0.50 |
| GBIO | Generation Bio Company | $36M | Healthcare | Biotechnology | 0.50 |
| WGS | GeneDx Holdings Corp - Class A | $1.96B | Healthcare | Diagnostics & Research | 0.50 |
| RIGL | Rigel Pharmaceuticals | $758M | Healthcare | Biotechnology | 0.49 |
| PVLA | Palvella Therapeutics Inc | $2.18B | Healthcare | Biotechnology | 0.49 |
| INTS | Intensity Therapeutics Inc | $12M | Healthcare | Biotechnology | 0.49 |
| FULTP | Fulton Financial Corp | $3.50B | Financial Services | Banks - Regional | 0.49 |
| TRTX | TPG RE Finance Trust Inc | $667M | Real Estate | Reit - Mortgage | 0.49 |
| COLAR | Columbus Acquisition Corp Rights | $778K | N/A | N/A | 0.49 |
| SCCF | Sachem Capital Corp | $1.18B | N/A | N/A | 0.48 |
| NTWOU | Newbury Street II Acquisition Corp - Units (1 Ord Cls A & 1/2 War) | $184M | Financial Services | Shell Companies | 0.48 |
| TWCB | Bilander Acquisition Corp - Class A | $230M | N/A | N/A | 0.47 |
| RMMZ | RiverNorth Managed Duration Municipal Income Fund II Inc | $126M | Financial Services | Asset Management | 0.47 |
| TFINP | Triumph Financial Inc | $529M | Financial Services | Banks - Regional | 0.47 |
| RFMZ | RiverNorth Flexible Municipal Income Fund II Inc | $312M | Financial Services | Asset Management | 0.47 |
| BPYPP | Brookfield Property Partners L.P. | $10B | Real Estate | Real Estate Services | 0.47 |
| GOODO | Gladstone Commercial Corp | $477M | Real Estate | Residential & Commercial Reits | 0.47 |
| BBNX | Beta Bionics Inc | $751M | Healthcare | Medical Devices | 0.47 |
| NTRP | Neurotrope Inc | $29M | Consumer Cyclical | Travel Services | 0.47 |
| ADCT | Adc Therapeutics SA | $163M | Healthcare | Biotechnology | 0.47 |